Aigialomycins A−E, New Resorcylic Macrolides from the Marine Mangrove Fungus Aigialus parvus
摘要:
Aigialomycins A-E (2-6), new 14-membered resorcylic macrolides, were isolated together with a known hypothemycin (1) from the mangrove fungus, Aigialus parvus BCC 5311. Structures of these compounds, including absolute configuration, were elucidated by spectroscopic methods, chemical conversions, and X-ray crystallographic analysis. Hypothemycin and aigialomycin D (5) exhibited in vitro antimalarial activity with IC50 values of 2.2 and 6.6 mug/mL, respectively, while other analogues were inactive. Cytotoxicities of these compounds were also evaluated.
Non-aromatic difluoro analogues of resorcylic acid lactones
申请人:The University of North Carolina at Greensboro
公开号:US10434085B2
公开(公告)日:2019-10-08
This disclosure is directed to non-aromatic difluoro analogues of resorcylic acid lactones, pharmaceutical compositions comprising non-aromatic difluoro analogues of resorcylic acid lactones, and methods of treatment comprising non-aromatic difluoro analogues of resorcylic acid lactones.
MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF KINASES AND HSP90
申请人:Université de Strasbourg
公开号:EP2136799B1
公开(公告)日:2017-10-04
NON-AROMATIC DIFLUORO ANALOGUES OF RESORCYLIC ACID LACTONES
申请人:Pearce Cedric
公开号:US20180153854A1
公开(公告)日:2018-06-07
This disclosure is directed to non-aromatic difluoro analogues of resorcylic acid lactones, pharmaceutical compositions comprising non-aromatic difluoro analogues of resorcylic acid lactones, and methods of treatment comprising non-aromatic difluoro analogues of resorcylic acid lactones.
[EN] NON-AROMATIC DIFLUORO ANALOGUES OF RESORCYLIC ACID LACTONES<br/>[FR] ANALOGUES DIFLUORO NON-AROMATIQUES DE LACTONES D'ACIDE RÉSORCYLIQUE
申请人:UNIV OF NORTH CAROLINA AT GREENSBORO
公开号:WO2016196256A2
公开(公告)日:2016-12-08
This disclosure is directed to non-aromatic difluoro analogues of resorcylic acid lactones, pharmaceutical compositions comprising non-aromatic difluoro analogues of resorcylic acid lactones, and methods of treatment comprising non-aromatic difluoro analogues of resorcylic acid lactones.